All In Biotech

Drug Trial Radar · NCT05669625

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of Live Attenuated Varicella Vaccine in Healthy People

Last checked: Nov 20, 2026Latest source record: Jun 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 12,440 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

12,440

Actual

Start

Dec 26, 2022

Primary completion

Apr 14, 2024

Study completion Sep 14, 2026

Sponsor

Sponsor type
Industry
Collaborators
Beijing Institute of Biological Products Co Ltd.; Jiangsu Province Centers for Disease Control and Prevention
First posted
Jan 3, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 1 year, up to 59 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate the efficacy, safety and immunogenicity of a live attenuated varicella vaccine manufactured by Beijing Institute of Biological Products Co., Ltd in healthy children.

Conditions

  • Varicella

Interventions

  • Investigational live attenuated varicella vaccineBiological

    0.5 ml/vial

  • Placebo of live attenuated varicella vaccineBiological

    0.5 ml/vial

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidences of varicella in each groupTime frame: number of cases reported 30 days after vaccination
  2. The efficacy of the live attenuated varicella vaccineTime frame: number of cases reported 30 days after vaccination

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Sinan County Center for Disease Control and Prevention

    Tongren, Guizhou, China

  • Songtao Miao Autonomous County Center for Disease Control and Prevention

    Tongren, Guizhou, China

  • Yuping Dong Autonomous County Center for Disease Control and Prevention

    Tongren, Guizhou, China

  • Qi County Center for Disease Control and Prevention

    Hebi, Henan, China

  • Wuzhi County Center for Disease Control and Prevention

    Jiaozuo, Henan, China

  • Wuyang County Center for Disease Control and Prevention

    Luohe, Henan, China

  • Pei County Center for Disease Control and Prevention

    Xuzhou, Jiangsu, China

  • Huaiyin District Center for Disease Control and Prevention

    Xuzhou, Jiangsu, China

  • Mianyang Anzhou District Center for Disease Control and Prevention

    Mianyang, Sichuan, China

  • Southern County Center for Disease Control and Prevention

    Nanchong, Sichuan, China

  • Neijiang City Center for Disease Control and Prevention

    Neijiang, Sichuan, China

  • Lancang Lahu Autonomous County Center for Disease Control and Prevention

    Pu'er, Yunnan, China

  • Yanshan County Center for Disease Control and Prevention

    Wenshan, Yunnan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.